Providence St. Peter Hospital

Olympia, Washington 98506

1 studies enrolling now · 11 studies all time

What they study most

Acute Ischemic Stroke, Brain Infarction, COVID-19, Cardiovascular Diseases, Central Line Associated Blood Stream Infections (CLABSI), Cerebral Ischemia, Cerebrovascular Accident, Coronary Artery Disease, Heart Diseases, Heart Failure, Heart Failure, Congestive, Hypertension

Studies at this site

• Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction — Recruiting now
• AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke — Stopped early
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) — Completed
• Prevalence, Awareness and Management of Hypertension in Acute Care Personnel — Completed
• The Dual Antiplatelet Therapy Study (DAPT Study) — Completed
• Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function — Completed
• Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients — Stopped early
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early
• A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator) — Completed
• A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients — Completed